Skip to main content

Spondyloarthritis

      RT @ericdeinmd: #ACR21 Abst#0916. https://t.co/uc5JDVY0ud
      Your patient has had 1 yr of remission of AxSpa on Certolizuma

      Eric Dein ericdeinmd

      3 years 11 months ago
      #ACR21 Abst#0916. https://t.co/uc5JDVY0ud Your patient has had 1 yr of remission of AxSpa on Certolizumab pegol, tolerating the medication. What do you recommend @Rheumnow
      Opening Day Report
      The opening of ACR2 Convergence was a hit for all who signed up and viewed in. The day included the presidential address by outgoing president Dr. David Karp (UT Southwestern) and a keynote talk and interview with Dr. Seema Yasmin (Stanford). The Year in Review featured a clinical vs basic science Brigham and Women’s Hospital faceoff between its two faculty, Dr. Karen Costenbader and Dr. Michael Brenner.
      RT @KDAO2011: Ouch! Patients with AS can fracture with minor trauma
      #ACR21 Radiology Bootcamp https://t.co/1piKvKUM2w

      TheDaoIndex KDAO2011

      3 years 11 months ago
      Ouch! Patients with AS can fracture with minor trauma #ACR21 Radiology Bootcamp https://t.co/1piKvKUM2w
      RT @KDAO2011: #ACR21 Radiology Bootcamp-- pretty helpful if you're studying for #ABIMRheumBoards

      Do you know how to dis

      TheDaoIndex KDAO2011

      3 years 11 months ago
      #ACR21 Radiology Bootcamp-- pretty helpful if you're studying for #ABIMRheumBoards Do you know how to distinguish sacroiliitis from pseudo-sacroiliitis? https://t.co/btS8mm8yH8
      Growing awareness of spondyloarthropathies over the last two decades has led to a better understanding of the pathophysiology of spondyloarthritis, and subsequently increased interest in more distinct, disease state specific treatment options.
      RT @_Castillo_Pedro: Excellent talk by Dr. Anna Molto. Characteristics of spondyloarthritis, noting some patients with P

      Pedro Castillo _Castillo_Pedro

      3 years 11 months ago
      Excellent talk by Dr. Anna Molto. Characteristics of spondyloarthritis, noting some patients with PsA have radiographic and non-radiographic axial SpA. #ACR21 6S403 @RheumNow https://t.co/ycftOMrWO9
      RT @DrMiniDey: Excellent scientific session on #SpA at #ACR21 right now- especially like this clear diagram of pathophys

      Mrinalini Dey DrMiniDey

      3 years 11 months ago
      Excellent scientific session on #SpA at #ACR21 right now- especially like this clear diagram of pathophysiology and useful summary slide from Dr Nigil Haroon on differences between #axSpA and axial #PsA @RheumNow https://t.co/F7Ns7e9HQI
      RT @synovialjoints: “The differences and similarities between axial disease in psoriatic arthritis vs axial spondyloar

      Dr. Antoni Chan synovialjoints

      3 years 11 months ago
      “The differences and similarities between axial disease in psoriatic arthritis vs axial spondyloarthritis is just at the cusp of discovery” Nigil Haroon at session 6S403 @RheumNow #ACR21
      RT @DrMiniDey: My first video for #ACR21 for @RheumNow, discussing #SickLeave, #WorkParticipation and #WorkDisability in

      Mrinalini Dey DrMiniDey

      3 years 11 months ago
      My first video for #ACR21 for @RheumNow, discussing #SickLeave, #WorkParticipation and #WorkDisability in patients with #SpA, with a focus on abstracts 0380 and 0381 by @ElenaNikiUK #axspa #spondyloarthritis #arthritis #qualityoflife Watch it here👇🏼 https://t.co/MEQ4wkFxrx
      RT @swethaann23: Torgutalp et al.
      ⭐️Included Early axSpA - 166 nr-axSpA (symptom duration ≤5 y) and 135 with r-ax

      swethaann23 swethaann23

      3 years 11 months ago
      Torgutalp et al. ⭐️Included Early axSpA - 166 nr-axSpA (symptom duration ≤5 y) and 135 with r-axSpA (symptom duration ≤10 y) from German Cohort ⭐️Assessed TNFI use over 2 years and has shown🔽 in radiographic sacroiliitis progression. Abst#0451 #ACR21 @RheumNow #ACRBest https://t.co/xP0wMLSyGw
      RT @doctorRBC: IL-22 as a potential biomarker of AxSpA from non-inflammatory mimickers?

      ⬆️IL-22 in AxSpA vs. contro

      Robert B Chao, MD doctorRBC

      3 years 11 months ago
      IL-22 as a potential biomarker of AxSpA from non-inflammatory mimickers? ⬆️IL-22 in AxSpA vs. controls ⭐️IL-22 did not correlate w/ mSASSS, BASADI, ASDAS, CRP Abs#385 #ACR21 @RheumNow https://t.co/hNtStAluJH
      ×